Pranav Joshi, Manav Goud Vanga, Charishma Jonnadula, Minseong Lee, Victoria Gnenema, Ananya Jamdagneya, Sang-Hyun Lee, Bosung Ku, Moo-Yeal Lee
{"title":"Rocking-Induced Rapid Formation of Tumor Spheroids for Scalable 3D Tumor-Immune Coculture Assays","authors":"Pranav Joshi, Manav Goud Vanga, Charishma Jonnadula, Minseong Lee, Victoria Gnenema, Ananya Jamdagneya, Sang-Hyun Lee, Bosung Ku, Moo-Yeal Lee","doi":"10.1002/biot.70283","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Tumor spheroids are widely used to model the tumor microenvironment and evaluate immune-mediated cytotoxicity, but conventional methods such as ultralow-attachment and hanging-drop plates typically require 48–72 h to generate stable spheroids, limiting scalability and rapid testing. Here, we report a simple method for generating uniform tumor spheroids within 7–8 h using continuous rocking in standard multiwell plates. Computational fluid dynamics simulations showed that rocking produced mild oscillatory hydrodynamic conditions, with average shear stress ranging from 0.4 to 0.8 dyn/cm<sup>2</sup> and X-direction shear stress remaining near ±0.2 dyn/cm<sup>2</sup>, promoting controlled cell aggregation while maintaining spheroid integrity. Using this approach, Hep3B cells reproducibly formed spheroids 80–150 µm in diameter across multiple seeding densities, yielding thousands of spheroids per well. The spheroids were embedded in extracellular matrix and transferred to a 36PillarPlate for scalable 3D tumor-immune coculture assays. To demonstrate utility, Hep3B spheroids were cocultured with NK-92 cells in the presence or absence of the immunomodulator berberine. Berberine treatment enhanced NK-92 localization and spheroid disruption, resulting in reduced tumor viability. This approach reduces spheroid preparation time from days to hours and enables same-day integration into 3D assays, providing a practical platform for studying tumor-immune interactions and screening immunomodulatory therapeutics.</p>\n </div>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"21 7","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/biot.70283","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Tumor spheroids are widely used to model the tumor microenvironment and evaluate immune-mediated cytotoxicity, but conventional methods such as ultralow-attachment and hanging-drop plates typically require 48–72 h to generate stable spheroids, limiting scalability and rapid testing. Here, we report a simple method for generating uniform tumor spheroids within 7–8 h using continuous rocking in standard multiwell plates. Computational fluid dynamics simulations showed that rocking produced mild oscillatory hydrodynamic conditions, with average shear stress ranging from 0.4 to 0.8 dyn/cm2 and X-direction shear stress remaining near ±0.2 dyn/cm2, promoting controlled cell aggregation while maintaining spheroid integrity. Using this approach, Hep3B cells reproducibly formed spheroids 80–150 µm in diameter across multiple seeding densities, yielding thousands of spheroids per well. The spheroids were embedded in extracellular matrix and transferred to a 36PillarPlate for scalable 3D tumor-immune coculture assays. To demonstrate utility, Hep3B spheroids were cocultured with NK-92 cells in the presence or absence of the immunomodulator berberine. Berberine treatment enhanced NK-92 localization and spheroid disruption, resulting in reduced tumor viability. This approach reduces spheroid preparation time from days to hours and enables same-day integration into 3D assays, providing a practical platform for studying tumor-immune interactions and screening immunomodulatory therapeutics.
Biotechnology JournalBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍:
Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances.
In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office.
BTJ promotes a special emphasis on:
Systems Biotechnology
Synthetic Biology and Metabolic Engineering
Nanobiotechnology and Biomaterials
Tissue engineering, Regenerative Medicine and Stem cells
Gene Editing, Gene therapy and Immunotherapy
Omics technologies
Industrial Biotechnology, Biopharmaceuticals and Biocatalysis
Bioprocess engineering and Downstream processing
Plant Biotechnology
Biosafety, Biotech Ethics, Science Communication
Methods and Advances.